Neshima Medical
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
IsraelWebsite
www.neshimamedical.comRevenue
<$5 MillionIndustry
About Neshima Medical
Neshima Medical Org Chart
Is Neshima Medical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Neshima Medical has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Neshima Medical launches new products
Neshima Medical, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Neshima Medical
Funding: Get notified immidiatlly once Neshima Medical has new funding data
Check out if Neshima Medical is spiking on competitors!
Earning: See what the market has to say on Neshima Medical recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Neshima Medical had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Neshima Medical as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Neshima Medical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Neshima Medical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neshima Medical.
Neshima Medical Tech Stack
A closer look at the technologies used by Neshima Medical
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neshima Medical
Neshima Medical is focused on revolutionizing respiratory medicine through its innovative Liquid Foam Therapy (LiFT), which aims to deliver therapeutics directly to the lungs. The company's primary target population includes ventilated pneumonia patients, offering a solution that significantly increases drug concentrations in the lungs compared to... Read More